Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BBIO

BridgeBio Pharma Inc

May 29 • 01:05PM ET

67.46

-0.99 -1.45 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ASND BMRN MDGL ALNY IONS KRYS EXEL RARE ARWR VRTX

| Held by: VTI VB IWM VBK VXF XBI IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.75	Insider Own	13.74%	Shs Outstand	195.71M	Perf Week	-4.01%
Market Cap	13.21B	Forward P/E	109.20	EPS next Y	0.62	Insider Trans	-2.60%	Shs Float	169.02M	Perf Month	-4.91%
Enterprise Value	15.67B	PEG	-	EPS next Q	-0.59	Inst Own	91.01%	Short Float	14.30%	Perf Quarter	1.47%
Income	-721.55M	P/S	22.78	EPS this Y	42.04%	Inst Trans	5.84%	Short Ratio	10.04	Perf Half Y	-4.49%
Sales	579.96M	P/B	-	EPS next Y	128.20%	ROA	-64.06%	Short Interest	24.16M	Perf YTD	-11.81%
Book/sh	-11.64	P/C	14.04	EPS next 5Y	-	ROE	-	52W High	84.94 -20.58%	Perf Year	102.15%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	-5.07% 0.09%	ROIC	-135.35%	52W Low	31.77 112.33%	Perf 3Y	390.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.30% 127.44%	Gross Margin	94.69%	Volatility	4.57% 4.33%	Perf 5Y	13.95%
Dividend TTM	-	EV/Sales	27.01	EPS Y/Y TTM	-6.09%	Oper. Margin	-86.94%	ATR (14)	3.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	355.17%	Profit Margin	-124.41%	RSI (14)	46.17	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	4.35%	SMA20	-0.31%	Beta	0.99	Target Price	104.67
Payout	-	Debt/Eq	-	Sales Q/Q	66.78%	SMA50	-4.99%	Rel Volume	0.82	Prev Close	68.45
Employees	839	LT Debt/Eq	-	Earnings	May 07 AMC	SMA200	1.63%	Avg Volume	2.41M	Price	67.46
IPO	Jun 27, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.75% 9.24%	Trades		Volume	1,126,449	Change	-1.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)